Monday, 5 January 2009

Canadian Agency for Drugs and Technologies in Health

CDR is inviting comments and feedback on the proposed procedures and submission requirements for pre-NOC submissions as well as resubmissions based on a reduced list price during the embargo period. These new initiatives are proposed to facilitate earlier access to drugs without compromising the high quality of CDRreviews.
http://cadth.ca/index.php/en/cdr/process/cdr-consultations-december-2008

Computed tomographic colonography for colorectal cancer screening in an average risk screening population: systematic review and economic evaluation (HTA)http://www.cadth.ca/index.php/en/hta/reports-publications/search/publication/864

Home telehealth for chronic disease management (HTA).
http://www.cadth.ca/index.php/en/hta/reports-publications/search/publication/865

Granulocyte-colony stimulating factor for antiviral-associated neutropenia: systematic review
and economic evaluation (HTA).

http://www.cadth.ca/index.php/en/hta/reports-publications/search/publication/868

Overview of granulocyte-colony stimulating factor for antiviral-associated Neutropenia.
http://www.cadth.ca/index.php/en/hta/reports-publications/search/publication/869